Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. 

CEO
Belén Garijo López
CEOBelén Garijo López
Employees
76,493
Employees76,493
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
76,493
Employees76,493

SNY Key Statistics

Market cap
107.69B
Market cap107.69B
Price-Earnings ratio
22.81
Price-Earnings ratio22.81
Dividend yield
3.97%
Dividend yield3.97%
Average volume
1.92M
Average volume1.92M
High today
$45.22
High today$45.22
Low today
$44.20
Low today$44.20
Open price
$45.15
Open price$45.15
Volume
2.40M
Volume2.40M
52 Week high
$52.68
52 Week high$52.68
52 Week low
$40.89
52 Week low$40.89

SNY News

Bloomberg 1d
Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi - bloomberg.com

...

Boehringer Signs Deal for Owkin AI, Joining Astra and Sanofi - bloomberg.com
24/7 Wall St. 2d
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?

Investing Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story? Retail traders are piling into Novavax on cancer-vaccine specu...

Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story?
TipRanks 3d
Sanofi: Balanced Risk-Reward as Pipeline Setbacks and Dupixent LOE Temper Growth Outlook, With BD/M&A Execution Key to Equity Story

TD Cowen analyst Steve Scala maintained a Hold rating on Sanofi today and set a price target of $57.00. Steve Scala has given his Hold rating due to a combinat...

Analyst ratings

50%

of 8 ratings
Buy
50%
Hold
50%
Sell
0%

More SNY News

TipRanks 6d
Sanofi Extends Lunsekimig COPD Program With Long-Term Safety Study

Sanofi SA (SNY) announced an update on their ongoing clinical study. The study, officially titled “An Extension Study to Evaluate the Long-term Safety and Effi...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.